Literature DB >> 2018448

Chloramphenicol 1. Hazards of use and the current regulatory environment.

S W Page1.   

Abstract

Chloramphenicol is a broad-spectrum antibiotic which has enjoyed extensive use in both medical and veterinary practice. Shortly after its introduction in the late 1940s, the use of chloramphenicol was associated with the induction of an idiosyncratic form of aplastic anaemia in man. This rare and unpredictable adverse effect has since been associated not only with systemic use but with topical applications, as well as occupational exposure. Recognition of the small risk of a potentially fatal adverse reaction, together with the risk of selection of chloramphenicol-resistant pathogens, has led to restrictions on the veterinary uses of chloramphenicol. In Australia at present, the use of chloramphenicol is only permitted in small animals. Its use is specifically prohibited in food-producing animals, including horses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018448     DOI: 10.1111/j.1751-0813.1991.tb09826.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  4 in total

1.  Reduced itraconazole concentration and durations are successful in treating Batrachochytrium dendrobatidis infection in amphibians.

Authors:  Laura A Brannelly
Journal:  J Vis Exp       Date:  2014-03-14       Impact factor: 1.355

Review 2.  Antimicrobial therapy of skin and ear infections.

Authors:  P M Dowling
Journal:  Can Vet J       Date:  1996-11       Impact factor: 1.008

3.  Evaluation of amphotericin B and chloramphenicol as alternative drugs for treatment of chytridiomycosis and their impacts on innate skin defenses.

Authors:  Whitney M Holden; Alexander R Ebert; Peter F Canning; Louise A Rollins-Smith
Journal:  Appl Environ Microbiol       Date:  2014-04-25       Impact factor: 4.792

4.  Treatment trial of clinically ill corroboree frogs with chytridiomycosis with two triazole antifungals and electrolyte therapy.

Authors:  Laura A Brannelly; Lee F Skerratt; Lee Berger
Journal:  Vet Res Commun       Date:  2015-08-06       Impact factor: 2.459

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.